OBSP Spike Level Charts

OBSP Determination:

1,7-DIMETHYLXANTHINE (P-XANTHINE)

METHOD: 2440 , TESTIDCODE: 67446LCM56

Plotted Points Statistics

1,7-DIMETHYLXANTHINE (P-XANTHINE)

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	1	79%	.	79%	0%
>= Reporting Level	54	188%	97%	160%	41%
Total	55	186%	98%	158%	41%

Sample Statistics

1,7-DIMETHYLXANTHINE (P-XANTHINE)

Characteristic	N	%	% Basis
Plotted	55	98%	Spiked
Estimated Values	50	89%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	1	2%	Spiked
Spiked	56	.
False Negatives	0	0%	0 out of 56
Not Spiked	30	.
False Positives	0	0%	0 out of 30

OBSP Determination:

10-HYDROXY-AMITRIPTYLINE

METHOD: 2440 , TESTIDCODE: 67995LCM56

Plotted Points Statistics

10-HYDROXY-AMITRIPTYLINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	2	77%	30%	77%	31%
>= Reporting Level	29	75%	19%	69%	21%
Total	31	75%	19%	69%	21%

Sample Statistics

10-HYDROXY-AMITRIPTYLINE

Characteristic	N	%	% Basis
Plotted	31	100%	Spiked
Estimated Values	9	29%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	31	.
False Negatives	0	0%	0 out of 31
Not Spiked	55	.
False Positives	0	0%	0 out of 55

OBSP Determination:

ABACAVIR

METHOD: 2440 , TESTIDCODE: 68022LCM56

Plotted Points Statistics

ABACAVIR

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	2	56%	3%	56%	3%
>= Reporting Level	53	49%	18%	43%	26%
Total	55	49%	18%	44%	26%

Sample Statistics

ABACAVIR

Characteristic	N	%	% Basis
Plotted	55	100%	Spiked
Estimated Values	4	7%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	55	.
False Negatives	0	0%	0 out of 55
Not Spiked	31	.
False Positives	0	0%	0 out of 31

OBSP Determination:

ACETAMINOPHEN

METHOD: 2440 , TESTIDCODE: 67436LCM56

Plotted Points Statistics

ACETAMINOPHEN

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	8	91%	26%	95%	28%
>= Reporting Level	33	103%	37%	96%	20%
Total	41	101%	35%	96%	20%

Sample Statistics

ACETAMINOPHEN

Characteristic	N	%	% Basis
Plotted	41	75%	Spiked
Estimated Values	13	24%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	13	24%	Spiked
Spiked	55	.
False Negatives	1	2%	1 out of 55
Not Spiked	31	.
False Positives	0	0%	0 out of 31

OBSP Determination:

ACYCLOVIR

METHOD: 2440 , TESTIDCODE: 67484LCM56

Plotted Points Statistics

ACYCLOVIR

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	1	336%	.	336%	0%
>= Reporting Level	25	169%	128%	111%	156%
Total	26	176%	130%	118%	164%

Sample Statistics

ACYCLOVIR

Characteristic	N	%	% Basis
Plotted	26	74%	Spiked
Estimated Values	20	57%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	2	6%	Spiked
Spiked	35	.
False Negatives	7	20%	7 out of 35
Not Spiked	47	.
False Positives	16	34%	16 out of 47

OBSP Determination:

ALBUTEROL (SALBUTAMOL)

METHOD: 2440 , TESTIDCODE: 67437LCM56

Plotted Points Statistics

ALBUTEROL (SALBUTAMOL)

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	1	87%	.	87%	0%
>= Reporting Level	53	77%	12%	77%	11%
Total	54	77%	12%	77%	11%

Sample Statistics

ALBUTEROL (SALBUTAMOL)

Characteristic	N	%	% Basis
Plotted	54	98%	Spiked
Estimated Values	6	11%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	1	2%	Spiked
Spiked	55	.
False Negatives	0	0%	0 out of 55
Not Spiked	31	.
False Positives	0	0%	0 out of 31

OBSP Determination:

ALPRAZOLAM

METHOD: 2440 , TESTIDCODE: 68250LCM56

Plotted Points Statistics

ALPRAZOLAM

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	2	74%	51%	74%	54%
>= Reporting Level	52	83%	13%	80%	12%
Total	54	83%	15%	80%	12%

Sample Statistics

ALPRAZOLAM

Characteristic	N	%	% Basis
Plotted	54	100%	Spiked
Estimated Values	9	17%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	54	.
False Negatives	0	0%	0 out of 54
Not Spiked	31	.
False Positives	1	3%	1 out of 31

OBSP Determination:

AMITRIPTYLINE

METHOD: 2440 , TESTIDCODE: 67522LCM56

Plotted Points Statistics

AMITRIPTYLINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	2	27%	21%	27%	22%
>= Reporting Level	50	65%	15%	65%	16%
Total	52	63%	17%	64%	18%

Sample Statistics

AMITRIPTYLINE

Characteristic	N	%	% Basis
Plotted	52	98%	Spiked
Estimated Values	52	98%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	53	.
False Negatives	1	2%	1 out of 53
Not Spiked	33	.
False Positives	0	0%	0 out of 33

OBSP Determination:

AMPHETAMINE

METHOD: 2440 , TESTIDCODE: 67461LCM56

Plotted Points Statistics

AMPHETAMINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	1	71%	.	71%	0%
>= Reporting Level	51	80%	13%	78%	11%
Total	52	80%	13%	78%	11%

Sample Statistics

AMPHETAMINE

Characteristic	N	%	% Basis
Plotted	52	98%	Spiked
Estimated Values	3	6%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	1	2%	Spiked
Spiked	53	.
False Negatives	0	0%	0 out of 53
Not Spiked	33	.
False Positives	0	0%	0 out of 33

OBSP Determination:

ANTIPYRINE

METHOD: 2440 , TESTIDCODE: 67477LCM56

Plotted Points Statistics

ANTIPYRINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	2	68%	18%	68%	19%
>= Reporting Level	52	85%	12%	85%	9%
Total	54	84%	13%	84%	9%

Sample Statistics

ANTIPYRINE

Characteristic	N	%	% Basis
Plotted	54	100%	Spiked
Estimated Values	3	6%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	54	.
False Negatives	0	0%	0 out of 54
Not Spiked	32	.
False Positives	0	0%	0 out of 32

OBSP Determination:

ATENOLOL

METHOD: 2440 , TESTIDCODE: 67502LCM56

Plotted Points Statistics

ATENOLOL

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	53	101%	67%	75%	33%
Total	53	101%	67%	75%	33%

Sample Statistics

ATENOLOL

Characteristic	N	%	% Basis
Plotted	53	93%	Spiked
Estimated Values	2	4%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	2	4%	Spiked
Spiked	57	.
False Negatives	2	4%	2 out of 57
Not Spiked	29	.
False Positives	0	0%	0 out of 29

OBSP Determination:

ATRAZINE

METHOD: 2440 , TESTIDCODE: 65065LCM56

Plotted Points Statistics

ATRAZINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	2	70%	1%	70%	1%
>= Reporting Level	50	84%	13%	84%	12%
Total	52	83%	13%	83%	12%

Sample Statistics

ATRAZINE

Characteristic	N	%	% Basis
Plotted	52	93%	Spiked
Estimated Values	11	20%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	56	.
False Negatives	4	7%	4 out of 56
Not Spiked	30	.
False Positives	5	17%	5 out of 30

OBSP Determination:

BENZTROPINE

METHOD: 2440 , TESTIDCODE: 67997LCM56

Plotted Points Statistics

BENZTROPINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	1	173%	.	173%	0%
>= Reporting Level	48	58%	18%	55%	17%
Total	49	61%	24%	56%	18%

Sample Statistics

BENZTROPINE

Characteristic	N	%	% Basis
Plotted	49	91%	Spiked
Estimated Values	49	91%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	3	6%	Spiked
Spiked	54	.
False Negatives	2	4%	2 out of 54
Not Spiked	32	.
False Positives	1	3%	1 out of 32

OBSP Determination:

BETAMETHASONE

METHOD: 2440 , TESTIDCODE: 67485LCM56

Plotted Points Statistics

BETAMETHASONE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	2	34%	14%	34%	14%
>= Reporting Level	54	90%	18%	89%	15%
Total	56	88%	21%	88%	16%

Sample Statistics

BETAMETHASONE

Characteristic	N	%	% Basis
Plotted	56	100%	Spiked
Estimated Values	40	71%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	56	.
False Negatives	0	0%	0 out of 56
Not Spiked	30	.
False Positives	0	0%	0 out of 30

OBSP Determination:

BUPROPION

METHOD: 2440 , TESTIDCODE: 67439LCM56

Plotted Points Statistics

BUPROPION

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	2	74%	5%	74%	5%
>= Reporting Level	53	69%	12%	68%	11%
Total	55	69%	12%	69%	11%

Sample Statistics

BUPROPION

Characteristic	N	%	% Basis
Plotted	55	100%	Spiked
Estimated Values	1	2%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	55	.
False Negatives	0	0%	0 out of 55
Not Spiked	31	.
False Positives	0	0%	0 out of 31

OBSP Determination:

CAFFEINE

METHOD: 2440 , TESTIDCODE: 67440LCM56

Plotted Points Statistics

CAFFEINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	56	89%	15%	88%	12%
Total	56	89%	15%	88%	12%

Sample Statistics

CAFFEINE

Characteristic	N	%	% Basis
Plotted	56	100%	Spiked
Estimated Values	38	68%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	56	.
False Negatives	0	0%	0 out of 56
Not Spiked	30	.
False Positives	1	3%	1 out of 30

OBSP Determination:

CARBAMAZEPINE

METHOD: 2440 , TESTIDCODE: 67441LCM56

Plotted Points Statistics

CARBAMAZEPINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	1	90%	.	90%	0%
>= Reporting Level	54	81%	11%	80%	9%
Total	55	81%	11%	81%	10%

Sample Statistics

CARBAMAZEPINE

Characteristic	N	%	% Basis
Plotted	55	98%	Spiked
Estimated Values	5	9%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	1	2%	Spiked
Spiked	56	.
False Negatives	0	0%	0 out of 56
Not Spiked	30	.
False Positives	1	3%	1 out of 30

OBSP Determination:

CARISOPRODOL

METHOD: 2440 , TESTIDCODE: 67498LCM56

Plotted Points Statistics

CARISOPRODOL

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	16	85%	15%	81%	13%
>= Reporting Level	34	85%	13%	84%	14%
Total	50	85%	13%	83%	13%

Sample Statistics

CARISOPRODOL

Characteristic	N	%	% Basis
Plotted	50	100%	Spiked
Estimated Values	4	8%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	50	.
False Negatives	0	0%	0 out of 50
Not Spiked	36	.
False Positives	0	0%	0 out of 36

OBSP Determination:

CHLORPHENIRAMINE

METHOD: 2440 , TESTIDCODE: 67497LCM56

Plotted Points Statistics

CHLORPHENIRAMINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	23	61%	24%	59%	27%
>= Reporting Level	21	48%	12%	48%	11%
Total	44	55%	20%	50%	19%

Sample Statistics

CHLORPHENIRAMINE

Characteristic	N	%	% Basis
Plotted	44	86%	Spiked
Estimated Values	39	76%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	5	10%	Spiked
Spiked	51	.
False Negatives	2	4%	2 out of 51
Not Spiked	35	.
False Positives	0	0%	0 out of 35

OBSP Determination:

CIMETIDINE

METHOD: 2440 , TESTIDCODE: 67442LCM56

Plotted Points Statistics

CIMETIDINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	1	68%	.	68%	0%
>= Reporting Level	28	54%	28%	50%	28%
Total	29	54%	28%	50%	24%

Sample Statistics

CIMETIDINE

Characteristic	N	%	% Basis
Plotted	29	55%	Spiked
Estimated Values	29	55%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	7	13%	Spiked
Spiked	53	.
False Negatives	17	32%	17 out of 53
Not Spiked	33	.
False Positives	0	0%	0 out of 33

OBSP Determination:

CITALOPRAM

METHOD: 2440 , TESTIDCODE: 67505LCM56

Plotted Points Statistics

CITALOPRAM

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	36	60%	20%	60%	23%
Total	36	60%	20%	60%	23%

Sample Statistics

CITALOPRAM

Characteristic	N	%	% Basis
Plotted	36	100%	Spiked
Estimated Values	10	28%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	36	.
False Negatives	0	0%	0 out of 36
Not Spiked	50	.
False Positives	0	0%	0 out of 50

OBSP Determination:

CLONIDINE

METHOD: 2440 , TESTIDCODE: 67518LCM56

Plotted Points Statistics

CLONIDINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	2	73%	14%	73%	14%
>= Reporting Level	52	86%	13%	85%	9%
Total	54	86%	13%	84%	9%

Sample Statistics

CLONIDINE

Characteristic	N	%	% Basis
Plotted	54	100%	Spiked
Estimated Values	32	59%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	54	.
False Negatives	0	0%	0 out of 54
Not Spiked	32	.
False Positives	0	0%	0 out of 32

OBSP Determination:

CODEINE

METHOD: 2440 , TESTIDCODE: 67443LCM56

Plotted Points Statistics

CODEINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	51	88%	19%	86%	16%
Total	51	88%	19%	86%	16%

Sample Statistics

CODEINE

Characteristic	N	%	% Basis
Plotted	51	100%	Spiked
Estimated Values	6	12%	Spiked
Deleted Values	2	2%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	51	.
False Negatives	0	0%	0 out of 51
Not Spiked	35	.
False Positives	1	3%	1 out of 33

OBSP Determination:

COTININE

METHOD: 2440 , TESTIDCODE: 67444LCM56

Plotted Points Statistics

COTININE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	54	83%	12%	80%	15%
Total	54	83%	12%	80%	15%

Sample Statistics

COTININE

Characteristic	N	%	% Basis
Plotted	54	100%	Spiked
Estimated Values	6	11%	Spiked
Deleted Values	4	5%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	56	.
False Negatives	0	0%	0 out of 54
Not Spiked	30	.
False Positives	2	7%	2 out of 28

OBSP Determination:

DEHYDRONIFEDIPINE

METHOD: 2440 , TESTIDCODE: 67445LCM56

Plotted Points Statistics

DEHYDRONIFEDIPINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	55	62%	14%	58%	14%
Total	55	62%	14%	58%	14%

Sample Statistics

DEHYDRONIFEDIPINE

Characteristic	N	%	% Basis
Plotted	55	100%	Spiked
Estimated Values	20	36%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	55	.
False Negatives	0	0%	0 out of 55
Not Spiked	31	.
False Positives	0	0%	0 out of 31

OBSP Determination:

DESMETHYLDILTIAZEM

METHOD: 2440 , TESTIDCODE: 67999LCM56

Plotted Points Statistics

DESMETHYLDILTIAZEM

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	15	45%	16%	47%	17%
>= Reporting Level	27	43%	14%	43%	11%
Total	42	44%	15%	44%	12%

Sample Statistics

DESMETHYLDILTIAZEM

Characteristic	N	%	% Basis
Plotted	42	75%	Spiked
Estimated Values	42	75%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	11	20%	Spiked
Spiked	56	.
False Negatives	3	5%	3 out of 56
Not Spiked	30	.
False Positives	0	0%	0 out of 30

OBSP Determination:

DESVENLAFAXINE

METHOD: 2440 , TESTIDCODE: 68251LCM56

Plotted Points Statistics

DESVENLAFAXINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	28	85%	16%	86%	15%
>= Reporting Level	26	74%	13%	72%	17%
Total	54	80%	16%	82%	16%

Sample Statistics

DESVENLAFAXINE

Characteristic	N	%	% Basis
Plotted	54	100%	Spiked
Estimated Values	8	15%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	54	.
False Negatives	0	0%	0 out of 54
Not Spiked	32	.
False Positives	0	0%	0 out of 32

OBSP Determination:

DEXTROMETHORPHAN

METHOD: 2440 , TESTIDCODE: 67468LCM56

Plotted Points Statistics

DEXTROMETHORPHAN

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	2	50%	14%	50%	15%
>= Reporting Level	53	76%	23%	74%	18%
Total	55	75%	23%	71%	19%

Sample Statistics

DEXTROMETHORPHAN

Characteristic	N	%	% Basis
Plotted	55	100%	Spiked
Estimated Values	2	4%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	55	.
False Negatives	0	0%	0 out of 55
Not Spiked	31	.
False Positives	0	0%	0 out of 31

OBSP Determination:

DIAZEPAM (VALIUM)

METHOD: 2440 , TESTIDCODE: 67499LCM56

Plotted Points Statistics

DIAZEPAM (VALIUM)

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	52	80%	15%	81%	15%
Total	52	80%	15%	81%	15%

Sample Statistics

DIAZEPAM (VALIUM)

Characteristic	N	%	% Basis
Plotted	52	96%	Spiked
Estimated Values	6	11%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	2	4%	Spiked
Spiked	54	.
False Negatives	0	0%	0 out of 54
Not Spiked	32	.
False Positives	0	0%	0 out of 32

OBSP Determination:

DILTIAZEM

METHOD: 2440 , TESTIDCODE: 67519LCM56

Plotted Points Statistics

DILTIAZEM

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	54	274%	487%	70%	24%
Total	54	274%	487%	70%	24%

Sample Statistics

DILTIAZEM

Characteristic	N	%	% Basis
Plotted	54	98%	Spiked
Estimated Values	11	20%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	1	2%	Spiked
Spiked	55	.
False Negatives	0	0%	0 out of 55
Not Spiked	30	.
False Positives	1	3%	1 out of 30

OBSP Determination:

DIPHENHYDRAMINE

METHOD: 2440 , TESTIDCODE: 67447LCM56

Plotted Points Statistics

DIPHENHYDRAMINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	16	81%	22%	81%	16%
>= Reporting Level	34	77%	15%	77%	14%
Total	50	78%	17%	77%	15%

Sample Statistics

DIPHENHYDRAMINE

Characteristic	N	%	% Basis
Plotted	50	93%	Spiked
Estimated Values	13	24%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	2	4%	Spiked
Spiked	54	.
False Negatives	2	4%	2 out of 54
Not Spiked	32	.
False Positives	0	0%	0 out of 32

OBSP Determination:

DULOXETINE

METHOD: 2440 , TESTIDCODE: 67448LCM56

Plotted Points Statistics

DULOXETINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	31	52%	11%	53%	8%
Total	31	52%	11%	53%	8%

Sample Statistics

DULOXETINE

Characteristic	N	%	% Basis
Plotted	31	91%	Spiked
Estimated Values	14	41%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	2	6%	Spiked
Spiked	34	.
False Negatives	1	3%	1 out of 34
Not Spiked	52	.
False Positives	0	0%	0 out of 52

OBSP Determination:

ERYTHROMYCIN

METHOD: 2440 , TESTIDCODE: 67449LCM56

Plotted Points Statistics

ERYTHROMYCIN

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	17	27%	20%	20%	15%
Total	17	27%	20%	20%	15%

Sample Statistics

ERYTHROMYCIN

Characteristic	N	%	% Basis
Plotted	17	30%	Spiked
Estimated Values	15	26%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	11	19%	Spiked
Spiked	57	.
False Negatives	29	51%	29 out of 57
Not Spiked	29	.
False Positives	0	0%	0 out of 29

OBSP Determination:

EZETIMIBE

METHOD: 2440 , TESTIDCODE: 67487LCM56

Plotted Points Statistics

EZETIMIBE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	7	74%	36%	66%	20%
>= Reporting Level	38	60%	23%	60%	28%
Total	45	62%	26%	62%	25%

Sample Statistics

EZETIMIBE

Characteristic	N	%	% Basis
Plotted	45	80%	Spiked
Estimated Values	45	80%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	11	20%	Spiked
Spiked	56	.
False Negatives	0	0%	0 out of 56
Not Spiked	30	.
False Positives	0	0%	0 out of 30

OBSP Determination:

FADROZOLE

METHOD: 2440 , TESTIDCODE: 68012LCM56

Plotted Points Statistics

FADROZOLE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	55	63%	13%	59%	10%
Total	55	63%	13%	59%	10%

Sample Statistics

FADROZOLE

Characteristic	N	%	% Basis
Plotted	55	98%	Spiked
Estimated Values	5	9%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	56	.
False Negatives	1	2%	1 out of 56
Not Spiked	30	.
False Positives	0	0%	0 out of 30

OBSP Determination:

FAMOTIDINE

METHOD: 2440 , TESTIDCODE: 68000LCM56

Plotted Points Statistics

FAMOTIDINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	9	60%	18%	57%	6%
>= Reporting Level	26	32%	23%	21%	23%
Total	35	39%	25%	39%	33%

Sample Statistics

FAMOTIDINE

Characteristic	N	%	% Basis
Plotted	35	63%	Spiked
Estimated Values	35	63%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	12	21%	Spiked
Spiked	56	.
False Negatives	9	16%	9 out of 56
Not Spiked	30	.
False Positives	0	0%	0 out of 30

OBSP Determination:

FENOFIBRATE

METHOD: 2440 , TESTIDCODE: 67489LCM56

Plotted Points Statistics

FENOFIBRATE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	43	98%	224%	51%	18%
Total	43	98%	224%	51%	18%

Sample Statistics

FENOFIBRATE

Characteristic	N	%	% Basis
Plotted	43	80%	Spiked
Estimated Values	43	80%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	4	7%	Spiked
Spiked	54	.
False Negatives	7	13%	7 out of 54
Not Spiked	32	.
False Positives	0	0%	0 out of 32

OBSP Determination:

FEXOFENADINE

METHOD: 2440 , TESTIDCODE: 67510LCM56

Plotted Points Statistics

FEXOFENADINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	16	70%	13%	67%	10%
>= Reporting Level	36	67%	15%	64%	11%
Total	52	68%	14%	65%	10%

Sample Statistics

FEXOFENADINE

Characteristic	N	%	% Basis
Plotted	52	95%	Spiked
Estimated Values	11	20%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	2	4%	Spiked
Spiked	55	.
False Negatives	1	2%	1 out of 55
Not Spiked	31	.
False Positives	0	0%	0 out of 31

OBSP Determination:

FLUCONAZOLE

METHOD: 2440 , TESTIDCODE: 67478LCM56

Plotted Points Statistics

FLUCONAZOLE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	2	80%	13%	80%	14%
>= Reporting Level	52	86%	14%	85%	17%
Total	54	86%	14%	85%	17%

Sample Statistics

FLUCONAZOLE

Characteristic	N	%	% Basis
Plotted	54	100%	Spiked
Estimated Values	3	6%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	54	.
False Negatives	0	0%	0 out of 54
Not Spiked	32	.
False Positives	0	0%	0 out of 32

OBSP Determination:

FLUOXETINE

METHOD: 2440 , TESTIDCODE: 67450LCM56

Plotted Points Statistics

FLUOXETINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	55	59%	16%	57%	11%
Total	55	59%	16%	57%	11%

Sample Statistics

FLUOXETINE

Characteristic	N	%	% Basis
Plotted	55	100%	Spiked
Estimated Values	25	45%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	55	.
False Negatives	0	0%	0 out of 55
Not Spiked	31	.
False Positives	0	0%	0 out of 31

OBSP Determination:

FLUTICASONE PROPIONATE

METHOD: 2440 , TESTIDCODE: 67529LCM56

Plotted Points Statistics

FLUTICASONE PROPIONATE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	1	133%	.	133%	0%
>= Reporting Level	28	81%	97%	60%	15%
Total	29	83%	95%	61%	15%

Sample Statistics

FLUTICASONE PROPIONATE

Characteristic	N	%	% Basis
Plotted	29	83%	Spiked
Estimated Values	4	11%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	5	14%	Spiked
Spiked	35	.
False Negatives	1	3%	1 out of 35
Not Spiked	51	.
False Positives	0	0%	0 out of 51

OBSP Determination:

FLUVOXAMINE

METHOD: 2440 , TESTIDCODE: 67521LCM56

Plotted Points Statistics

FLUVOXAMINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	57	46%	15%	48%	16%
Total	57	46%	15%	48%	16%

Sample Statistics

FLUVOXAMINE

Characteristic	N	%	% Basis
Plotted	57	100%	Spiked
Estimated Values	57	100%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	57	.
False Negatives	0	0%	0 out of 57
Not Spiked	29	.
False Positives	0	0%	0 out of 29

OBSP Determination:

GLIPIZIDE

METHOD: 2440 , TESTIDCODE: 68001LCM56

Plotted Points Statistics

GLIPIZIDE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	56	82%	19%	79%	18%
Total	56	82%	19%	79%	18%

Sample Statistics

GLIPIZIDE

Characteristic	N	%	% Basis
Plotted	56	100%	Spiked
Estimated Values	18	32%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	56	.
False Negatives	0	0%	0 out of 56
Not Spiked	30	.
False Positives	0	0%	0 out of 30

OBSP Determination:

GLYBURIDE

METHOD: 2440 , TESTIDCODE: 68002LCM56

Plotted Points Statistics

GLYBURIDE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	26	73%	8%	72%	7%
>= Reporting Level	27	61%	21%	64%	24%
Total	53	67%	17%	69%	11%

Sample Statistics

GLYBURIDE

Characteristic	N	%	% Basis
Plotted	53	96%	Spiked
Estimated Values	10	18%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	2	4%	Spiked
Spiked	55	.
False Negatives	0	0%	0 out of 55
Not Spiked	31	.
False Positives	0	0%	0 out of 31

OBSP Determination:

GUANYLUREA

METHOD: 2440 , TESTIDCODE: 52816LCM56

Sample Statistics

GUANYLUREA

Characteristic	N	%	% Basis
Plotted	0	.	Spiked
Estimated Values	0	.	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	.	Spiked
Spiked	0	.
False Negatives	0	.	0 out of 0
Not Spiked	45	.
False Positives	0	0%	0 out of 45

OBSP Determination:

HYDROCODONE

METHOD: 2440 , TESTIDCODE: 67506LCM56

Plotted Points Statistics

HYDROCODONE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	43	85%	21%	85%	27%
Total	43	85%	21%	85%	27%

Sample Statistics

HYDROCODONE

Characteristic	N	%	% Basis
Plotted	43	83%	Spiked
Estimated Values	31	60%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	6	12%	Spiked
Spiked	52	.
False Negatives	3	6%	3 out of 52
Not Spiked	34	.
False Positives	0	0%	0 out of 34

OBSP Determination:

HYDROCORTISONE

METHOD: 2440 , TESTIDCODE: 67459LCM56

Plotted Points Statistics

HYDROCORTISONE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	50	84%	13%	82%	12%
Total	50	84%	13%	82%	12%

Sample Statistics

HYDROCORTISONE

Characteristic	N	%	% Basis
Plotted	50	93%	Spiked
Estimated Values	39	72%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	2	4%	Spiked
Spiked	54	.
False Negatives	2	4%	2 out of 54
Not Spiked	32	.
False Positives	0	0%	0 out of 32

OBSP Determination:

HYDROXYZINE

METHOD: 2440 , TESTIDCODE: 68005LCM56

Plotted Points Statistics

HYDROXYZINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	1	7%	.	7%	0%
>= Reporting Level	32	68%	13%	68%	13%
Total	33	66%	16%	67%	12%

Sample Statistics

HYDROXYZINE

Characteristic	N	%	% Basis
Plotted	33	97%	Spiked
Estimated Values	2	6%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	1	3%	Spiked
Spiked	34	.
False Negatives	0	0%	0 out of 34
Not Spiked	32	.
False Positives	0	0%	0 out of 32

OBSP Determination:

IMINOSTILBENE

METHOD: 2440 , TESTIDCODE: 67481LCM56

Plotted Points Statistics

IMINOSTILBENE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	53	87%	31%	83%	27%
Total	53	87%	31%	83%	27%

Sample Statistics

IMINOSTILBENE

Characteristic	N	%	% Basis
Plotted	53	96%	Spiked
Estimated Values	18	33%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	55	.
False Negatives	2	4%	2 out of 55
Not Spiked	31	.
False Positives	0	0%	0 out of 31

OBSP Determination:

KETOCONAZOLE

METHOD: 2440 , TESTIDCODE: 68014LCM56

Plotted Points Statistics

KETOCONAZOLE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	2	39%	7%	39%	7%
>= Reporting Level	51	57%	19%	54%	15%
Total	53	57%	19%	54%	13%

Sample Statistics

KETOCONAZOLE

Characteristic	N	%	% Basis
Plotted	53	98%	Spiked
Estimated Values	40	74%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	54	.
False Negatives	1	2%	1 out of 54
Not Spiked	32	.
False Positives	0	0%	0 out of 32

OBSP Determination:

LAMIVUDINE

METHOD: 2440 , TESTIDCODE: 68018LCM56

Plotted Points Statistics

LAMIVUDINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	44	80%	31%	76%	21%
Total	44	80%	31%	76%	21%

Sample Statistics

LAMIVUDINE

Characteristic	N	%	% Basis
Plotted	44	79%	Spiked
Estimated Values	31	55%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	2	4%	Spiked
Spiked	56	.
False Negatives	10	18%	10 out of 56
Not Spiked	30	.
False Positives	0	0%	0 out of 30

OBSP Determination:

LIDOCAINE

METHOD: 2440 , TESTIDCODE: 67462LCM56

Plotted Points Statistics

LIDOCAINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	15	90%	14%	88%	11%
>= Reporting Level	38	87%	12%	84%	12%
Total	53	88%	13%	87%	12%

Sample Statistics

LIDOCAINE

Characteristic	N	%	% Basis
Plotted	53	100%	Spiked
Estimated Values	4	8%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	53	.
False Negatives	0	0%	0 out of 53
Not Spiked	33	.
False Positives	0	0%	0 out of 33

OBSP Determination:

LOPERAMIDE

METHOD: 2440 , TESTIDCODE: 67515LCM56

Plotted Points Statistics

LOPERAMIDE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	28	62%	19%	68%	26%
>= Reporting Level	18	48%	17%	50%	18%
Total	46	57%	19%	55%	25%

Sample Statistics

LOPERAMIDE

Characteristic	N	%	% Basis
Plotted	46	87%	Spiked
Estimated Values	46	87%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	2	4%	Spiked
Spiked	53	.
False Negatives	5	9%	5 out of 53
Not Spiked	33	.
False Positives	0	0%	0 out of 33

OBSP Determination:

LORATADINE

METHOD: 2440 , TESTIDCODE: 67488LCM56

Plotted Points Statistics

LORATADINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	57	50%	25%	41%	15%
Total	57	50%	25%	41%	15%

Sample Statistics

LORATADINE

Characteristic	N	%	% Basis
Plotted	57	100%	Spiked
Estimated Values	23	40%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	57	.
False Negatives	0	0%	0 out of 57
Not Spiked	29	.
False Positives	0	0%	0 out of 29

OBSP Determination:

LORAZEPAM

METHOD: 2440 , TESTIDCODE: 67470LCM56

Plotted Points Statistics

LORAZEPAM

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	50	107%	25%	108%	19%
Total	50	107%	25%	108%	19%

Sample Statistics

LORAZEPAM

Characteristic	N	%	% Basis
Plotted	50	100%	Spiked
Estimated Values	40	80%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	50	.
False Negatives	0	0%	0 out of 50
Not Spiked	36	.
False Positives	0	0%	0 out of 36

OBSP Determination:

MEPROBAMATE

METHOD: 2440 , TESTIDCODE: 67464LCM56

Plotted Points Statistics

MEPROBAMATE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	2	86%	26%	86%	27%
>= Reporting Level	50	88%	11%	87%	11%
Total	52	88%	11%	87%	11%

Sample Statistics

MEPROBAMATE

Characteristic	N	%	% Basis
Plotted	52	100%	Spiked
Estimated Values	2	4%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	52	.
False Negatives	0	0%	0 out of 52
Not Spiked	34	.
False Positives	0	0%	0 out of 34

OBSP Determination:

METAXALONE

METHOD: 2440 , TESTIDCODE: 67504LCM56

Plotted Points Statistics

METAXALONE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	30	76%	18%	72%	15%
Total	30	76%	18%	72%	15%

Sample Statistics

METAXALONE

Characteristic	N	%	% Basis
Plotted	30	100%	Spiked
Estimated Values	14	47%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	30	.
False Negatives	0	0%	0 out of 30
Not Spiked	47	.
False Positives	6	13%	6 out of 47

OBSP Determination:

METFORMIN

METHOD: 2440 , TESTIDCODE: 67492LCM56

Plotted Points Statistics

METFORMIN

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	57	71%	20%	73%	14%
Total	57	71%	20%	73%	14%

Sample Statistics

METFORMIN

Characteristic	N	%	% Basis
Plotted	57	100%	Spiked
Estimated Values	6	11%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	57	.
False Negatives	0	0%	0 out of 57
Not Spiked	29	.
False Positives	0	0%	0 out of 29

OBSP Determination:

METHADONE

METHOD: 2440 , TESTIDCODE: 67500LCM56

Plotted Points Statistics

METHADONE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	52	78%	18%	75%	18%
Total	52	78%	18%	75%	18%

Sample Statistics

METHADONE

Characteristic	N	%	% Basis
Plotted	52	96%	Spiked
Estimated Values	7	13%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	2	4%	Spiked
Spiked	54	.
False Negatives	0	0%	0 out of 54
Not Spiked	32	.
False Positives	0	0%	0 out of 32

OBSP Determination:

METHOCARBAMOL

METHOD: 2440 , TESTIDCODE: 67501LCM56

Plotted Points Statistics

METHOCARBAMOL

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	53	87%	16%	86%	15%
Total	53	87%	16%	86%	15%

Sample Statistics

METHOCARBAMOL

Characteristic	N	%	% Basis
Plotted	53	95%	Spiked
Estimated Values	10	18%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	3	5%	Spiked
Spiked	56	.
False Negatives	0	0%	0 out of 56
Not Spiked	30	.
False Positives	1	3%	1 out of 30

OBSP Determination:

METHOTREXATE

METHOD: 2440 , TESTIDCODE: 67525LCM56

Plotted Points Statistics

METHOTREXATE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	42	45%	14%	44%	14%
Total	42	45%	14%	44%	14%

Sample Statistics

METHOTREXATE

Characteristic	N	%	% Basis
Plotted	42	75%	Spiked
Estimated Values	19	34%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	3	5%	Spiked
Spiked	56	.
False Negatives	11	20%	11 out of 56
Not Spiked	30	.
False Positives	0	0%	0 out of 30

OBSP Determination:

METHYL-1H-BENZOTRIAZOLE

METHOD: 2440 , TESTIDCODE: 67514LCM56

Plotted Points Statistics

METHYL-1H-BENZOTRIAZOLE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	2	95%	6%	95%	7%
>= Reporting Level	53	88%	12%	87%	9%
Total	55	88%	12%	87%	9%

Sample Statistics

METHYL-1H-BENZOTRIAZOLE

Characteristic	N	%	% Basis
Plotted	55	100%	Spiked
Estimated Values	5	9%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	55	.
False Negatives	0	0%	0 out of 55
Not Spiked	31	.
False Positives	0	0%	0 out of 31

OBSP Determination:

METOPROLOL

METHOD: 2440 , TESTIDCODE: 67523LCM56

Plotted Points Statistics

METOPROLOL

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	2	32%	4%	32%	5%
>= Reporting Level	53	48%	22%	38%	9%
Total	55	47%	22%	38%	10%

Sample Statistics

METOPROLOL

Characteristic	N	%	% Basis
Plotted	55	100%	Spiked
Estimated Values	2	4%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	55	.
False Negatives	0	0%	0 out of 55
Not Spiked	31	.
False Positives	0	0%	0 out of 31

OBSP Determination:

MORPHINE

METHOD: 2440 , TESTIDCODE: 67458LCM56

Plotted Points Statistics

MORPHINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	23	111%	57%	89%	35%
>= Reporting Level	25	86%	27%	80%	10%
Total	48	98%	45%	81%	19%

Sample Statistics

MORPHINE

Characteristic	N	%	% Basis
Plotted	48	91%	Spiked
Estimated Values	6	11%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	3	6%	Spiked
Spiked	53	.
False Negatives	2	4%	2 out of 53
Not Spiked	33	.
False Positives	0	0%	0 out of 33

OBSP Determination:

NADALOL

METHOD: 2440 , TESTIDCODE: 68006LCM56

Plotted Points Statistics

NADALOL

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	2	76%	18%	76%	19%
>= Reporting Level	54	85%	15%	82%	11%
Total	56	85%	15%	82%	11%

Sample Statistics

NADALOL

Characteristic	N	%	% Basis
Plotted	56	100%	Spiked
Estimated Values	7	13%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	56	.
False Negatives	0	0%	0 out of 56
Not Spiked	30	.
False Positives	0	0%	0 out of 30

OBSP Determination:

NEVIRAPINE

METHOD: 2440 , TESTIDCODE: 68017LCM56

Plotted Points Statistics

NEVIRAPINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	28	81%	10%	81%	7%
>= Reporting Level	28	83%	15%	79%	17%
Total	56	82%	13%	80%	11%

Sample Statistics

NEVIRAPINE

Characteristic	N	%	% Basis
Plotted	56	100%	Spiked
Estimated Values	2	4%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	56	.
False Negatives	0	0%	0 out of 56
Not Spiked	30	.
False Positives	0	0%	0 out of 30

OBSP Determination:

NICOTINE

METHOD: 2440 , TESTIDCODE: 67493LCM56

Plotted Points Statistics

NICOTINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	49	40%	17%	37%	16%
Total	49	40%	17%	37%	16%

Sample Statistics

NICOTINE

Characteristic	N	%	% Basis
Plotted	49	91%	Spiked
Estimated Values	36	67%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	2	4%	Spiked
Spiked	54	.
False Negatives	3	6%	3 out of 54
Not Spiked	32	.
False Positives	0	0%	0 out of 32

OBSP Determination:

NIZATIDINE

METHOD: 2440 , TESTIDCODE: 67479LCM56

Plotted Points Statistics

NIZATIDINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	8	64%	22%	68%	5%
>= Reporting Level	26	36%	23%	36%	30%
Total	34	43%	25%	44%	37%

Sample Statistics

NIZATIDINE

Characteristic	N	%	% Basis
Plotted	34	62%	Spiked
Estimated Values	34	62%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	9	16%	Spiked
Spiked	55	.
False Negatives	12	22%	12 out of 55
Not Spiked	31	.
False Positives	0	0%	0 out of 31

OBSP Determination:

NORDIAZEPAM

METHOD: 2440 , TESTIDCODE: 68252LCM56

Plotted Points Statistics

NORDIAZEPAM

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	52	82%	11%	81%	10%
Total	52	82%	11%	81%	10%

Sample Statistics

NORDIAZEPAM

Characteristic	N	%	% Basis
Plotted	52	100%	Spiked
Estimated Values	5	10%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	52	.
False Negatives	0	0%	0 out of 52
Not Spiked	34	.
False Positives	0	0%	0 out of 34

OBSP Determination:

NORETHINDRONE

METHOD: 2440 , TESTIDCODE: 67434LCM56

Plotted Points Statistics

NORETHINDRONE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	1	65%	.	65%	0%
>= Reporting Level	49	78%	12%	79%	11%
Total	50	78%	12%	79%	11%

Sample Statistics

NORETHINDRONE

Characteristic	N	%	% Basis
Plotted	50	89%	Spiked
Estimated Values	3	5%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	5	9%	Spiked
Spiked	56	.
False Negatives	1	2%	1 out of 56
Not Spiked	30	.
False Positives	0	0%	0 out of 30

OBSP Determination:

NORFLUOXETINE

METHOD: 2440 , TESTIDCODE: 67451LCM56

Plotted Points Statistics

NORFLUOXETINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	36	57%	13%	57%	11%
Total	36	57%	13%	57%	11%

Sample Statistics

NORFLUOXETINE

Characteristic	N	%	% Basis
Plotted	36	100%	Spiked
Estimated Values	21	58%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	36	.
False Negatives	0	0%	0 out of 36
Not Spiked	50	.
False Positives	0	0%	0 out of 50

OBSP Determination:

NORSERTRALINE

METHOD: 2440 , TESTIDCODE: 67532LCM56

Plotted Points Statistics

NORSERTRALINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	28	56%	12%	55%	12%
Total	28	56%	12%	55%	12%

Sample Statistics

NORSERTRALINE

Characteristic	N	%	% Basis
Plotted	28	100%	Spiked
Estimated Values	28	100%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	28	.
False Negatives	0	0%	0 out of 28
Not Spiked	58	.
False Positives	0	0%	0 out of 58

OBSP Determination:

NORVERAPAMIL

METHOD: 2440 , TESTIDCODE: 68007LCM56

Plotted Points Statistics

NORVERAPAMIL

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	1	13%	.	13%	0%
>= Reporting Level	32	40%	11%	41%	9%
Total	33	39%	12%	40%	9%

Sample Statistics

NORVERAPAMIL

Characteristic	N	%	% Basis
Plotted	33	92%	Spiked
Estimated Values	33	92%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	3	8%	Spiked
Spiked	36	.
False Negatives	0	0%	0 out of 36
Not Spiked	50	.
False Positives	0	0%	0 out of 50

OBSP Determination:

OMEPRAZOLE + ESOMEPRAZOLE

METHOD: 2440 , TESTIDCODE: 67512LCM56

Plotted Points Statistics

OMEPRAZOLE + ESOMEPRAZOLE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	10	55%	66%	32%	9%
>= Reporting Level	35	42%	28%	33%	18%
Total	45	45%	39%	33%	14%

Sample Statistics

OMEPRAZOLE + ESOMEPRAZOLE

Characteristic	N	%	% Basis
Plotted	45	82%	Spiked
Estimated Values	11	20%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	9	16%	Spiked
Spiked	55	.
False Negatives	1	2%	1 out of 55
Not Spiked	31	.
False Positives	0	0%	0 out of 31

OBSP Determination:

OSELTAMIVIR

METHOD: 2440 , TESTIDCODE: 67511LCM56

Plotted Points Statistics

OSELTAMIVIR

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	52	51%	13%	49%	13%
Total	52	51%	13%	49%	13%

Sample Statistics

OSELTAMIVIR

Characteristic	N	%	% Basis
Plotted	52	96%	Spiked
Estimated Values	16	30%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	2	4%	Spiked
Spiked	54	.
False Negatives	0	0%	0 out of 54
Not Spiked	32	.
False Positives	0	0%	0 out of 32

OBSP Determination:

OXAZEPAM

METHOD: 2440 , TESTIDCODE: 67469LCM56

Plotted Points Statistics

OXAZEPAM

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	51	71%	30%	72%	41%
Total	51	71%	30%	72%	41%

Sample Statistics

OXAZEPAM

Characteristic	N	%	% Basis
Plotted	51	94%	Spiked
Estimated Values	40	74%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	2	4%	Spiked
Spiked	54	.
False Negatives	1	2%	1 out of 54
Not Spiked	32	.
False Positives	0	0%	0 out of 32

OBSP Determination:

OXYCODONE

METHOD: 2440 , TESTIDCODE: 67495LCM56

Plotted Points Statistics

OXYCODONE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	50	80%	18%	77%	14%
Total	50	80%	18%	77%	14%

Sample Statistics

OXYCODONE

Characteristic	N	%	% Basis
Plotted	50	96%	Spiked
Estimated Values	8	15%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	2	4%	Spiked
Spiked	52	.
False Negatives	0	0%	0 out of 52
Not Spiked	34	.
False Positives	0	0%	0 out of 34

OBSP Determination:

PAROXETINE

METHOD: 2440 , TESTIDCODE: 67527LCM56

Plotted Points Statistics

PAROXETINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	26	60%	14%	58%	14%
>= Reporting Level	27	57%	18%	56%	17%
Total	53	58%	16%	58%	15%

Sample Statistics

PAROXETINE

Characteristic	N	%	% Basis
Plotted	53	95%	Spiked
Estimated Values	53	95%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	56	.
False Negatives	3	5%	3 out of 56
Not Spiked	30	.
False Positives	0	0%	0 out of 30

OBSP Determination:

PENCICLOVIR

METHOD: 2440 , TESTIDCODE: 68021LCM56

Plotted Points Statistics

PENCICLOVIR

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	1	142%	.	142%	0%
>= Reporting Level	40	72%	33%	71%	40%
Total	41	74%	34%	72%	40%

Sample Statistics

PENCICLOVIR

Characteristic	N	%	% Basis
Plotted	41	75%	Spiked
Estimated Values	26	47%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	6	11%	Spiked
Spiked	55	.
False Negatives	8	15%	8 out of 55
Not Spiked	31	.
False Positives	0	0%	0 out of 31

OBSP Determination:

PENTOXIFYLLINE

METHOD: 2440 , TESTIDCODE: 67480LCM56

Plotted Points Statistics

PENTOXIFYLLINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	2	50%	3%	50%	3%
>= Reporting Level	52	78%	10%	76%	9%
Total	54	77%	11%	76%	10%

Sample Statistics

PENTOXIFYLLINE

Characteristic	N	%	% Basis
Plotted	54	98%	Spiked
Estimated Values	1	2%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	55	.
False Negatives	1	2%	1 out of 55
Not Spiked	31	.
False Positives	0	0%	0 out of 31

OBSP Determination:

PHENAZOPYRIDINE

METHOD: 2440 , TESTIDCODE: 68008LCM56

Plotted Points Statistics

PHENAZOPYRIDINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	54	95%	27%	91%	24%
Total	54	95%	27%	91%	24%

Sample Statistics

PHENAZOPYRIDINE

Characteristic	N	%	% Basis
Plotted	54	96%	Spiked
Estimated Values	11	20%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	2	4%	Spiked
Spiked	56	.
False Negatives	0	0%	0 out of 56
Not Spiked	30	.
False Positives	0	0%	0 out of 30

OBSP Determination:

PHENDIMETRAZINE

METHOD: 2440 , TESTIDCODE: 67496LCM56

Sample Statistics

PHENDIMETRAZINE

Characteristic	N	%	% Basis
Plotted	0	.	Spiked
Estimated Values	0	.	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	.	Spiked
Spiked	0	.
False Negatives	0	.	0 out of 0
Not Spiked	86	.
False Positives	0	0%	0 out of 86

OBSP Determination:

PHENYTOIN

METHOD: 2440 , TESTIDCODE: 67466LCM56

Plotted Points Statistics

PHENYTOIN

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	56	94%	15%	94%	18%
Total	56	94%	15%	94%	18%

Sample Statistics

PHENYTOIN

Characteristic	N	%	% Basis
Plotted	56	100%	Spiked
Estimated Values	40	71%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	56	.
False Negatives	0	0%	0 out of 56
Not Spiked	30	.
False Positives	0	0%	0 out of 30

OBSP Determination:

PIPERONYL BUTOXIDE

METHOD: 2440 , TESTIDCODE: 67435LCM56

Plotted Points Statistics

PIPERONYL BUTOXIDE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	23	170%	391%	52%	23%
>= Reporting Level	23	59%	48%	40%	25%
Total	46	114%	281%	46%	25%

Sample Statistics

PIPERONYL BUTOXIDE

Characteristic	N	%	% Basis
Plotted	46	81%	Spiked
Estimated Values	39	68%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	9	16%	Spiked
Spiked	57	.
False Negatives	2	4%	2 out of 57
Not Spiked	29	.
False Positives	0	0%	0 out of 29

OBSP Determination:

PREDNISOLONE

METHOD: 2440 , TESTIDCODE: 67483LCM56

Plotted Points Statistics

PREDNISOLONE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	2	98%	26%	98%	27%
>= Reporting Level	53	83%	14%	80%	13%
Total	55	83%	15%	80%	13%

Sample Statistics

PREDNISOLONE

Characteristic	N	%	% Basis
Plotted	55	100%	Spiked
Estimated Values	11	20%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	55	.
False Negatives	0	0%	0 out of 55
Not Spiked	31	.
False Positives	0	0%	0 out of 31

OBSP Determination:

PREDNISONE

METHOD: 2440 , TESTIDCODE: 67467LCM56

Plotted Points Statistics

PREDNISONE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	56	91%	15%	88%	15%
Total	56	91%	15%	88%	15%

Sample Statistics

PREDNISONE

Characteristic	N	%	% Basis
Plotted	56	100%	Spiked
Estimated Values	45	80%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	56	.
False Negatives	0	0%	0 out of 56
Not Spiked	30	.
False Positives	0	0%	0 out of 30

OBSP Determination:

PROMETHAZINE

METHOD: 2440 , TESTIDCODE: 67524LCM56

Plotted Points Statistics

PROMETHAZINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	6	88%	155%	28%	11%
Total	6	88%	155%	28%	11%

Sample Statistics

PROMETHAZINE

Characteristic	N	%	% Basis
Plotted	6	11%	Spiked
Estimated Values	6	11%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	4	7%	Spiked
Spiked	56	.
False Negatives	46	82%	46 out of 56
Not Spiked	30	.
False Positives	0	0%	0 out of 30

OBSP Determination:

PROPOXYPHENE

METHOD: 2440 , TESTIDCODE: 68009LCM56

Plotted Points Statistics

PROPOXYPHENE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	1	19%	.	19%	0%
>= Reporting Level	54	73%	18%	73%	19%
Total	55	72%	20%	71%	20%

Sample Statistics

PROPOXYPHENE

Characteristic	N	%	% Basis
Plotted	55	98%	Spiked
Estimated Values	45	80%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	1	2%	Spiked
Spiked	56	.
False Negatives	0	0%	0 out of 56
Not Spiked	30	.
False Positives	0	0%	0 out of 30

OBSP Determination:

PROPRANOLOL

METHOD: 2440 , TESTIDCODE: 67516LCM56

Plotted Points Statistics

PROPRANOLOL

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	1	49%	.	49%	0%
>= Reporting Level	51	76%	12%	77%	9%
Total	52	76%	12%	77%	9%

Sample Statistics

PROPRANOLOL

Characteristic	N	%	% Basis
Plotted	52	95%	Spiked
Estimated Values	1	2%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	3	5%	Spiked
Spiked	55	.
False Negatives	0	0%	0 out of 55
Not Spiked	31	.
False Positives	0	0%	0 out of 31

OBSP Determination:

PSEUDOEPHEDRINE+EPHEDRINE

METHOD: 2440 , TESTIDCODE: 67460LCM56

Plotted Points Statistics

PSEUDOEPHEDRINE+EPHEDRINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	8	54%	15%	48%	13%
Total	8	54%	15%	48%	13%

Sample Statistics

PSEUDOEPHEDRINE+EPHEDRINE

Characteristic	N	%	% Basis
Plotted	8	100%	Spiked
Estimated Values	2	25%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	8	.
False Negatives	0	0%	0 out of 8
Not Spiked	58	.
False Positives	0	0%	0 out of 58

OBSP Determination:

QUININE

METHOD: 2440 , TESTIDCODE: 68011LCM56

Plotted Points Statistics

QUININE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	57	65%	13%	64%	13%
Total	57	65%	13%	64%	13%

Sample Statistics

QUININE

Characteristic	N	%	% Basis
Plotted	57	100%	Spiked
Estimated Values	30	53%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	57	.
False Negatives	0	0%	0 out of 57
Not Spiked	29	.
False Positives	0	0%	0 out of 29

OBSP Determination:

RACTOPAMINE

METHOD: 2440 , TESTIDCODE: 52814LCM56

Sample Statistics

RACTOPAMINE

Characteristic	N	%	% Basis
Plotted	0	.	Spiked
Estimated Values	0	.	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	.	Spiked
Spiked	0	.
False Negatives	0	.	0 out of 0
Not Spiked	45	.
False Positives	0	0%	0 out of 45

OBSP Determination:

RALOXIFENE

METHOD: 2440 , TESTIDCODE: 67530LCM56

Plotted Points Statistics

RALOXIFENE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	21	43%	13%	40%	14%
>= Reporting Level	23	53%	64%	33%	15%
Total	44	48%	47%	38%	19%

Sample Statistics

RALOXIFENE

Characteristic	N	%	% Basis
Plotted	44	81%	Spiked
Estimated Values	44	81%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	9	17%	Spiked
Spiked	54	.
False Negatives	1	2%	1 out of 54
Not Spiked	32	.
False Positives	0	0%	0 out of 32

OBSP Determination:

RANITIDINE

METHOD: 2440 , TESTIDCODE: 67452LCM56

Plotted Points Statistics

RANITIDINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	22	37%	20%	43%	23%
Total	22	37%	20%	43%	23%

Sample Statistics

RANITIDINE

Characteristic	N	%	% Basis
Plotted	22	50%	Spiked
Estimated Values	22	50%	Spiked
Deleted Values	13	15%	Spiked + Not Spiked
Spiked, Censored	2	5%	Spiked
Spiked	54	.
False Negatives	20	45%	20 out of 44
Not Spiked	32	.
False Positives	0	0%	0 out of 29

OBSP Determination:

SERTRALINE

METHOD: 2440 , TESTIDCODE: 67528LCM56

Plotted Points Statistics

SERTRALINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	53	44%	13%	42%	12%
Total	53	44%	13%	42%	12%

Sample Statistics

SERTRALINE

Characteristic	N	%	% Basis
Plotted	53	96%	Spiked
Estimated Values	53	96%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	2	4%	Spiked
Spiked	55	.
False Negatives	0	0%	0 out of 55
Not Spiked	31	.
False Positives	0	0%	0 out of 31

OBSP Determination:

SITAGLIPTIN

METHOD: 2440 , TESTIDCODE: 67531LCM56

Plotted Points Statistics

SITAGLIPTIN

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	2	104%	34%	104%	36%
>= Reporting Level	52	74%	17%	73%	13%
Total	54	75%	18%	73%	13%

Sample Statistics

SITAGLIPTIN

Characteristic	N	%	% Basis
Plotted	54	100%	Spiked
Estimated Values	11	20%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	54	.
False Negatives	0	0%	0 out of 54
Not Spiked	32	.
False Positives	0	0%	0 out of 32

OBSP Determination:

SULFADIMETHOXINE

METHOD: 2440 , TESTIDCODE: 67503LCM56

Plotted Points Statistics

SULFADIMETHOXINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	57	93%	15%	92%	15%
Total	57	93%	15%	92%	15%

Sample Statistics

SULFADIMETHOXINE

Characteristic	N	%	% Basis
Plotted	57	100%	Spiked
Estimated Values	7	12%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	57	.
False Negatives	0	0%	0 out of 57
Not Spiked	29	.
False Positives	1	3%	1 out of 29

OBSP Determination:

SULFAMETHIZOLE

METHOD: 2440 , TESTIDCODE: 67476LCM56

Plotted Points Statistics

SULFAMETHIZOLE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	56	77%	11%	77%	6%
Total	56	77%	11%	77%	6%

Sample Statistics

SULFAMETHIZOLE

Characteristic	N	%	% Basis
Plotted	56	100%	Spiked
Estimated Values	2	4%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	56	.
False Negatives	0	0%	0 out of 56
Not Spiked	30	.
False Positives	0	0%	0 out of 30

OBSP Determination:

SULFAMETHOXAZOLE

METHOD: 2440 , TESTIDCODE: 67454LCM56

Plotted Points Statistics

SULFAMETHOXAZOLE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	1	63%	.	63%	0%
>= Reporting Level	54	85%	15%	82%	16%
Total	55	85%	15%	81%	16%

Sample Statistics

SULFAMETHOXAZOLE

Characteristic	N	%	% Basis
Plotted	55	98%	Spiked
Estimated Values	2	4%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	1	2%	Spiked
Spiked	56	.
False Negatives	0	0%	0 out of 56
Not Spiked	30	.
False Positives	0	0%	0 out of 30

OBSP Determination:

TAMOXIFEN

METHOD: 2440 , TESTIDCODE: 68015LCM56

Plotted Points Statistics

TAMOXIFEN

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	3	25%	1%	25%	2%
Total	3	25%	1%	25%	2%

Sample Statistics

TAMOXIFEN

Characteristic	N	%	% Basis
Plotted	3	6%	Spiked
Estimated Values	3	6%	Spiked
Deleted Values	15	17%	Spiked + Not Spiked
Spiked, Censored	12	26%	Spiked
Spiked	56	.
False Negatives	32	68%	32 out of 47
Not Spiked	30	.
False Positives	0	0%	0 out of 24

OBSP Determination:

TEMAZEPAM

METHOD: 2440 , TESTIDCODE: 67471LCM56

Plotted Points Statistics

TEMAZEPAM

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	43	64%	34%	79%	46%
Total	43	64%	34%	79%	46%

Sample Statistics

TEMAZEPAM

Characteristic	N	%	% Basis
Plotted	43	81%	Spiked
Estimated Values	4	8%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	7	13%	Spiked
Spiked	53	.
False Negatives	3	6%	3 out of 53
Not Spiked	33	.
False Positives	0	0%	0 out of 33

OBSP Determination:

THEOPHYLLINE

METHOD: 2440 , TESTIDCODE: 67494LCM56

Plotted Points Statistics

THEOPHYLLINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	25	88%	18%	92%	18%
Total	25	88%	18%	92%	18%

Sample Statistics

THEOPHYLLINE

Characteristic	N	%	% Basis
Plotted	25	69%	Spiked
Estimated Values	15	42%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	9	25%	Spiked
Spiked	36	.
False Negatives	2	6%	2 out of 36
Not Spiked	48	.
False Positives	10	21%	10 out of 48

OBSP Determination:

THIABENDAZOLE

METHOD: 2440 , TESTIDCODE: 67455LCM56

Plotted Points Statistics

THIABENDAZOLE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	12	78%	9%	78%	9%
>= Reporting Level	36	77%	13%	76%	10%
Total	48	78%	12%	77%	9%

Sample Statistics

THIABENDAZOLE

Characteristic	N	%	% Basis
Plotted	48	87%	Spiked
Estimated Values	21	38%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	4	7%	Spiked
Spiked	55	.
False Negatives	3	5%	3 out of 55
Not Spiked	31	.
False Positives	0	0%	0 out of 31

OBSP Determination:

TIOTROPIUM

METHOD: 2440 , TESTIDCODE: 67508LCM56

Plotted Points Statistics

TIOTROPIUM

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	6	42%	10%	41%	13%
>= Reporting Level	22	42%	47%	30%	21%
Total	28	42%	41%	32%	22%

Sample Statistics

TIOTROPIUM

Characteristic	N	%	% Basis
Plotted	28	82%	Spiked
Estimated Values	28	82%	Spiked
Deleted Values	1	1%	Spiked + Not Spiked
Spiked, Censored	1	3%	Spiked
Spiked	35	.
False Negatives	5	15%	5 out of 34
Not Spiked	51	.
False Positives	0	0%	0 out of 51

OBSP Determination:

TRAMADOL

METHOD: 2440 , TESTIDCODE: 67517LCM56

Plotted Points Statistics

TRAMADOL

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	31	85%	12%	84%	11%
Total	31	85%	12%	84%	11%

Sample Statistics

TRAMADOL

Characteristic	N	%	% Basis
Plotted	31	97%	Spiked
Estimated Values	4	13%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	32	.
False Negatives	1	3%	1 out of 32
Not Spiked	54	.
False Positives	0	0%	0 out of 54

OBSP Determination:

TRIAMTERENE

METHOD: 2440 , TESTIDCODE: 67475LCM56

Plotted Points Statistics

TRIAMTERENE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	54	72%	12%	72%	11%
Total	54	72%	12%	72%	11%

Sample Statistics

TRIAMTERENE

Characteristic	N	%	% Basis
Plotted	54	96%	Spiked
Estimated Values	8	14%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	56	.
False Negatives	2	4%	2 out of 56
Not Spiked	30	.
False Positives	0	0%	0 out of 30

OBSP Determination:

TRIMETHOPRIM

METHOD: 2440 , TESTIDCODE: 67456LCM56

Plotted Points Statistics

TRIMETHOPRIM

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	56	79%	13%	80%	13%
Total	56	79%	13%	80%	13%

Sample Statistics

TRIMETHOPRIM

Characteristic	N	%	% Basis
Plotted	56	100%	Spiked
Estimated Values	2	4%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	56	.
False Negatives	0	0%	0 out of 56
Not Spiked	30	.
False Positives	0	0%	0 out of 30

OBSP Determination:

VALACYCLOVIR

METHOD: 2440 , TESTIDCODE: 67507LCM56

Plotted Points Statistics

VALACYCLOVIR

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	30	34%	15%	29%	9%
Total	30	34%	15%	29%	9%

Sample Statistics

VALACYCLOVIR

Characteristic	N	%	% Basis
Plotted	30	88%	Spiked
Estimated Values	30	88%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	2	6%	Spiked
Spiked	34	.
False Negatives	2	6%	2 out of 34
Not Spiked	52	.
False Positives	0	0%	0 out of 52

OBSP Determination:

VENLAFAXINE

METHOD: 2440 , TESTIDCODE: 67534LCM56

Plotted Points Statistics

VENLAFAXINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	1	64%	.	64%	0%
>= Reporting Level	52	72%	15%	73%	18%
Total	53	72%	15%	72%	18%

Sample Statistics

VENLAFAXINE

Characteristic	N	%	% Basis
Plotted	53	98%	Spiked
Estimated Values	5	9%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	1	2%	Spiked
Spiked	54	.
False Negatives	0	0%	0 out of 54
Not Spiked	32	.
False Positives	0	0%	0 out of 32

OBSP Determination:

VERAPAMIL

METHOD: 2440 , TESTIDCODE: 67472LCM56

Plotted Points Statistics

VERAPAMIL

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	27	88%	73%	69%	63%
>= Reporting Level	29	41%	18%	41%	21%
Total	56	64%	57%	47%	32%

Sample Statistics

VERAPAMIL

Characteristic	N	%	% Basis
Plotted	56	100%	Spiked
Estimated Values	41	73%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	56	.
False Negatives	0	0%	0 out of 56
Not Spiked	30	.
False Positives	0	0%	0 out of 30

OBSP Determination:

WARFARIN

METHOD: 2440 , TESTIDCODE: 67457LCM56

Plotted Points Statistics

WARFARIN

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	52	84%	29%	79%	31%
Total	52	84%	29%	79%	31%

Sample Statistics

WARFARIN

Characteristic	N	%	% Basis
Plotted	52	96%	Spiked
Estimated Values	7	13%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	2	4%	Spiked
Spiked	54	.
False Negatives	0	0%	0 out of 54
Not Spiked	32	.
False Positives	0	0%	0 out of 32